These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Del Amo EM; Urtti A Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911 [TBL] [Abstract][Full Text] [Related]
33. Formulary of commonly used ophthalmologic medications. Zun LS; Mathews J Emerg Med Clin North Am; 1988 Feb; 6(1):121-6. PubMed ID: 3345712 [TBL] [Abstract][Full Text] [Related]
34. Comparative study of two corticosteroid antimicrobial ophthalmic preparations. Breakey AS Eye Ear Nose Throat Mon; 1969 Nov; 48(11):632-5. PubMed ID: 5346002 [No Abstract] [Full Text] [Related]
35. Topical diethylcarbamazine in ocular onchocerciasis. Aviel E; David R Isr J Med Sci; 1972; 8(8):1166-8. PubMed ID: 4647766 [No Abstract] [Full Text] [Related]
36. [Using therapeutic drugs. Drug storage and administration. Drugs used on the eye]. Kircher W Med Monatsschr Pharm; 1990 Aug; 13(8):253-6. PubMed ID: 2398839 [No Abstract] [Full Text] [Related]
37. Nonhypotensive autonomic agents in veterinary ophthalmology. Klauss G; Constantinescu GM Vet Clin North Am Small Anim Pract; 2004 May; 34(3):777-800. PubMed ID: 15110984 [TBL] [Abstract][Full Text] [Related]
38. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. Myles ME; Neumann DM; Hill JM Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884 [TBL] [Abstract][Full Text] [Related]
39. Chitosan nanoparticles for drug delivery to the eye. Paolicelli P; de la Fuente M; Sánchez A; Seijo B; Alonso MJ Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841 [TBL] [Abstract][Full Text] [Related]
40. [Ocular dressing with installation of eye drops]. André F Soins; 1985 May; (453):III-IV. PubMed ID: 3854514 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]